Clinical Respiratory Medicine

Organisational unit: Research group

More filtering options
  1. 2021
  2. Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

    Franziska Roth-Walter, Ian M. Adcock, Cristina Benito-Villalvilla, Rodolfo Bianchini, Leif Bjermer, Onur Boyman, Gaetano Caramori, Luigi Cari, Kian Fan Chung, Zuzana Diamant, Ibon Eguiluz-Gracia, Edward F. Knol, Antonios Kolios, Francesca Levi-Schaffer, Giuseppe Nocentini, Oscar Palomares, Frank Redegeld, Betty Van Esch & Cristiana Stellato, 2021, In: Allergy: European Journal of Allergy and Clinical Immunology. 76, 1, p. 90-113 24 p.

    Research output: Contribution to journalArticle

  3. 2020
  4. A new role for “eat me” and “don’t eat me” markers on neutrophils in asthmatic airway inflammation

    Sandra Ekstedt, Ellen Tufvesson, Leif Bjermer, Susanna Kumlien Georén & Lars Olaf Cardell, 2020 Jun, In: Allergy: European Journal of Allergy and Clinical Immunology. 75, 6, p. 1510-1512 3 p.

    Research output: Contribution to journalLetter

  5. Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

    Glenis K. Scadding, Peter W. Hellings, Claus Bachert, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann & Ulrich Wahn, 2020 May 16, In: World Allergy Organization Journal. 13, 5, 100124.

    Research output: Contribution to journalLetter

  6. Nordstar: Paving the way for a new era in asthma research

    Kirk Geale, Hatef Darabi, Maria Lindh, Hanna Fues Wahl, Oskar Ström, Hui Cao, Luisa Alvares, Rikke Dodge, Emil Loefroth, Alan Altraja, Vibeke Backer, Helena Backman, Leif Bjermer, Apostolos Bossios, Bernt Bøgvald Aarli, Barbro Dahlén, Ole Hilberg, Christer Janson, Hannu Kankaanranta, Jussi Karjalainen & 12 others, Paula Kauppi, Maritta Kilpeläinen, Sverre Lehmann, Lauri Lehtimäki, Bo Lundbäck, Thomas Sandström, Charlotte Suppli Ulrik, Asger Sverrild, Arja Viinanen, Anna von Bülow, Valentyna Yasinska & Celeste Porsbjerg, 2020 Apr, In: European Respiratory Journal. 55, 4, 1902476.

    Research output: Contribution to journalArticle

  7. Clinical characteristics of the BREATHE cohort–a real-life study on patients with asthma and COPD

    Vibeke Backer, Ditte K. Klein, Uffe Bodtger, Kerstin Romberg, Celeste Porsbjerg, Jonas S. Erjefält, Karsten Kristiansen, Ruiqi Xu, Alexander Silberbrandt, Laurits Frøssing, Morten Hvidtfeldt, Nicolai Obling, Linnea Jarenbäck, Abir Nasr, Ellen Tufvesson, Michiko Mori, Matilde Winther-Jensen, Lisa Karlsson, Ulf Nihlén, Thomas Veje Flintegaard & 1 others, Leif Bjermer, 2020 Mar 17, In: European clinical respiratory journal. 7, 1, 1736934.

    Research output: Contribution to journalArticle

  8. Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

    Edward M. Kerwin, Isabelle H. Boucot, Claus F. Vogelmeier, Francois Maltais, Ian P. Naya, Lee Tombs, Paul W. Jones, David A. Lipson, Tom Keeley & Leif Bjermer, 2020, In: Therapeutic Advances in Respiratory Disease. 14

    Research output: Contribution to journalArticle

  9. Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue

    Prajakta Jogdand, Premkumar Siddhuraj, Michiko Mori, Caroline Sanden, Jimmie Jönsson, Andrew F. Walls, Jennifer Kearley, Alison A. Humbles, Roland Kolbeck, Leif Bjermer, Paul Newbold & Jonas S. Erjefält, 2020, In: European Respiratory Journal. 55, 4

    Research output: Contribution to journalArticle

  10. Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial

    Claus F. Vogelmeier, Edward M. Kerwin, Leif H. Bjermer, Lee Tombs, Paul W. Jones, Isabelle H. Boucot, Ian P. Naya, David A. Lipson, Chris Compton, Neil Barnes & François Maltais, 2020, In: Therapeutic Advances in Respiratory Disease. 14

    Research output: Contribution to journalArticle

  11. Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

    F. Maltais, I. P. Naya, C. F. Vogelmeier, I. H. Boucot, P. W. Jones, L. Bjermer, L. Tombs, C. Compton, D. A. Lipson & E. M. Kerwin, 2020, In: Respiratory Research. 21, 1, 280.

    Research output: Contribution to journalArticle

  12. 2019